GIBTULIO MET 12.5/1000 (Empagliflozin (12.5mg) + Metformin (1000mg))

GIBTULIO MET 12.5/1000 is a medication often used to help manage blood sugar levels in adults with type 2 diabetes. It supports patients by assisting their bodies in utilizing glucose more effectively, contributing to overall metabolic control.

The active ingredients, Empagliflozin and Metformin, work together to address high blood sugar. Empagliflozin helps the kidneys remove excess glucose from the bloodstream, while Metformin improves insulin sensitivity and reduces glucose production in the liver. This combination can help patients maintain healthier blood sugar levels.

For best results, store GIBTULIO MET in a cool and dry place, away from direct sunlight and moisture. Consistent use is important for effective management, and it is advisable to regularly monitor blood sugar levels. Patients should always discuss any concerns or pre-existing conditions with their healthcare provider before starting the medication.

While many people tolerate GIBTULIO MET well, some may experience mild side effects such as digestive issues, including stomach upset or diarrhea, as well as increased urination. These effects often diminish over time, but it is important to communicate with a healthcare professional if they persist or worsen.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.